Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...
US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based ...
Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...
Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...
The biotech infrastructure sector has changed significantly since the biotechnology funding peak of 2021. Less venture ...
UK clinical-stage biotech Elevara Medicines today announced the appointment of Mai-Britt Zocca as chief executive (CEO), ...
Japanese drugmaker Eisai today announced the latest findings on etalanetug (development code: E2814) showed that this ...
Elevar Therapeutics, a majority-owned subsidiary of South Korea's HLB (Kosdaq: 028300), has received a complete response ...
Medicines regulators in several major markets have issued a mix of approvals, safety communications, supply notices, ...
US RNA medicines focused biotech Stoke Therapeutics today announced that Thomas McCauley has been appointed chief scientific ...
Last week’s regulatory news saw the US Food and Drug Administration (FDA) accept Swiss biotech Pharmvaris’ new drug application (NDA) for deucrictibant for the treatment hereditary angioedema (HAE) ...
GSK (LSE: GSK) has terminated its neurodegeneration collaboration with Alector (Nasdaq: ALEC), ending an alliance established ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results